ヒトパピローマウイルス感染症：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Human Papillomavirus Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Human Papillomavirus Infections 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Human Papillomavirus Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Human Papillomavirus Infections 33
Jun 16, 2015: Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001, Company’s First-in-class HPV Therapeutic Vaccine Candidate 33
Apr 20, 2015: Genticel to Present Further Promising Pharmacology In-Vivo Results of Its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (ProCervix), at AACR Annual Meeting 2015 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
GlaxoSmithKline Plc 34
Clinical Trial Overview of GlaxoSmithKline Plc 34
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Merck Sharp & Dohme Corp. 42
Clinical Trial Overview of Merck Sharp & Dohme Corp. 42
Valeant Pharmaceuticals International, Inc. 45
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 45
Medicis Pharmaceutical Corporation 46
Clinical Trial Overview of Medicis Pharmaceutical Corporation 46
Genticel S.A. 47
Clinical Trial Overview of Genticel S.A. 47
Nestle S.A. 48
Clinical Trial Overview of Nestle S.A. 48
BioMAS Ltd. 49
Clinical Trial Overview of BioMAS Ltd. 49
AstraZeneca Plc 50
Clinical Trial Overview of AstraZeneca Plc 50
Akela Pharma Inc. (Inactive) 51
Clinical Trial Overview of Akela Pharma Inc. (Inactive) 51
Clinical Trial Overview of Top Institutes / Government 52
The National Institute of Allergy and Infectious Diseases 52
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
AIDS Malignancy Clinical Trials Consortium 55
Clinical Trial Overview of AIDS Malignancy Clinical Trials Consortium 55
Leiden University Medical Center 56
Clinical Trial Overview of Leiden University Medical Center 56
Medical University of Vienna 57
Clinical Trial Overview of Medical University of Vienna 57
Dana-Farber Cancer Institute, Inc. 58
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 58
Duke University 59
Clinical Trial Overview of Duke University 59
Second Affiliated Hospital of Shanxi Medical University 60
Clinical Trial Overview of Second Affiliated Hospital of Shanxi Medical University 60
Shiraz University of Medical Sciences 61
Clinical Trial Overview of Shiraz University of Medical Sciences 61
The Johns Hopkins University 62
Clinical Trial Overview of The Johns Hopkins University 62
Five Key Clinical Profiles 63
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120